DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...

"Based on insights from six in-depth reports, this review explores how breakthroughs in sequencing, RNAi, and viral vector technologies will shape the future of biotech through 2029.”Boston, July 07, ...

Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...

Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, today announced a ...

Epitopea, a transatlantic cancer immunotherapeutics company, has announced the formation of a dedicated clinical team and the ...

RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurpos ...